Susquehanna International Group, LLP Aeterna Zentaris Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.17 - $0.37 $4,871 - $10,601	-28,654 Reduced 13.17%	188,993 $37,000
Q1 2022 May 16, 2022	SELL	$0.33 - $0.42 $55,962 - $71,224	-169,583 Reduced 43.79%	217,647 $79,000
Q4 2021 Feb 14, 2022	SELL	$0.36 - $0.77 $9,115 - $19,496	-25,320 Reduced 6.14%	387,230 $138,000
Q3 2021 Nov 15, 2021	BUY	$0.59 - $0.88 $78,314 - $116,807	132,736 Added 47.44%	412,550 $309,000
Q2 2021 Aug 11, 2021	SELL	$0.83 - $1.14 $50,784 - $69,752	-61,186 Reduced 17.94%	279,814 $245,000
Q1 2021 May 17, 2021	BUY	$0.51 - $3.34 $165,715 - $1.09 Million	324,932 Added 2022.23%	341,000 $389,000
Q3 2019 Nov 14, 2019	SELL	$1.0 - $2.97 $51,773 - $153,765	-51,773 Reduced 76.32%	16,068 $17,000
Q1 2019 May 15, 2019	BUY	$3.03 - $4.65 $107,534 - $165,028	35,490 Added 109.7%	67,841 $315,000
Q4 2018 Feb 14, 2019	BUY	$1.3 - $3.87 $9,137 - $27,202	7,029 Added 27.76%	32,351 $95,000
Q3 2018 Nov 14, 2018	SELL	$1.6 - $2.03 $29,315 - $37,193	-18,322 Reduced 41.98%	25,322 $44,000
Q2 2018 Aug 14, 2018	SELL	$1.19 - $2.62 $35,955 - $79,163	-30,215 Reduced 40.91%	43,644 $85,000
Q1 2018 May 15, 2018	BUY	$1.46 - $2.41 $79,689 - $131,542	54,582 Added 283.15%	73,859 $108,000
Q4 2017 Feb 14, 2018	SELL	$1.87 - $2.7 $14,395 - $20,784	-7,698 Reduced 28.54%	19,277 $46,000
Q3 2017 Nov 20, 2017	BUY	$1.81 - $2.23 $48,824 - $60,154	26,975	26,975 $55,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.